Pharmafile Logo
Pharmafocus logo
Advanced Search

Investors ramp up pressure on AZ chief

April 10, 2012
Sales and Marketing AstraZeneca, David Brennan

AstraZeneca’s chief executive David Brennan is coming under increasing pressure from investors, and his future at the firm could be …

News

Codexis and Merck develop green Victrelis production

April 10, 2012
Manufacturing and Production Codexis, Merck, manufacturing

Merck has teamed up with catalyst specialist Codexis to develop a more efficient manufacturing process for recently-approved hepatitis C treatment …

News

Alzheimer’s diagnostic comes with caveats

April 10, 2012
Sales and Marketing Alzheimer's, Amyvid, lilly

A first-in-class test for Alzheimer’s disease has been approved by the FDA, but its makers have stressed its limitations.Lilly’s Amyvid …

News
Novo Nordisk HQ

Victoza superiority to Januvia made official by FDA

April 10, 2012
Medical Communications, Sales and Marketing Januvia, Merck, Novo Nordisk, Victoza, diabetes

Novo Nordisk is now able to claim superiority for its diabetes drug Victoza compared to Merck’s rival treatment Januvia.The US …

News

Sheri McCoy resigns from Johnson & Johnson

April 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johnson & Johnson, Sheri McCoy, resignation

Johnson & Johnson has announced that Sheri McCoy, vice chairman of the executive committee, will leave the company on April …

Appointment

Submission of labels and leaflets in the UK

April 5, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Labelling, Wainwright Associates

The MHRA has announced procedural changes concerning the requirement to submit full-colour mock-ups of labels and patient leaflets for medicinal …

News
Press release

Pfizer heart drug gains new licence in UK

April 5, 2012
Sales and Marketing Inspra, NHS, Pfizer, heart failure

Pfizer’s heart pill Inspra has gained a new licence in the UK to reduce the risk of death in patients …

News
Diabetes nest image

Roche sponsors Twitter-based diabetes community

April 5, 2012
Medical Communications Ignite Health, Roche, Twitter, diabetes

Roche is to sponsor a Twitter-based site devoted talk about diabetes, furthering its close links with online commentators.  ‘Diabetes Nest’ …

News
Brain image

The brain drain

April 5, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, R&D, brain drain, research and development

Concerns about the growing number of companies disinvesting from neuroscience research have been growing in recent years, and the latest …

Feature

Eric Abadie resigns as chair of the CHMP

April 5, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, Eric Abadie

Dr Eric Abadie has told the European Medicines Agency that he is resigning as chair of the Committee for Medicinal …

Appointment

FDA grants priority review for Sanofi cancer drug

April 5, 2012
Research and Development, Sales and Marketing Erbitux, FDA, Regeneron, Sanofi, Zaltrap, colorectal cancer, prostate cancer

The FDA has granted Sanofi and partner Regeneron priority review for their colorectal cancer drug Zaltrap. Zaltrap (aflibercept) is seeking a …

News

Drugmakers ‘premature’ in requests for metal impurity data

April 5, 2012
Manufacturing and Production ICH, manufacturing, metal impurity

Pharmaceutical manufacturers are acting ‘prematurely’ when asking excipient suppliers to provide metal impurity levels, according to a new position paper …

News
Lonza picture

Lonza names Ridinger as new chief executive

April 5, 2012
Manufacturing and Production Cognis, Lonza, Ridinger

Swiss contract manufacturer and ingredients supplier Lonza has appointed Richard Ridinger as its new chief executive, replacing Stefan Borgas who …

News

AstraZeneca signs respiratory pact with Amgen

April 5, 2012
Research and Development Amgen, AstraZeneca, MedImmune, respiratory

AstraZeneca has bought its way into Amgen’s inflammation portfolio with a $50 million upfront payment to co-develop and commercialise five …

News

Orphan Medicinal Products in the EU- Free Webinar

April 4, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Orphan Medicinal Products in the EU: Eligibility, Orphan Designation and IncentivesThe structure of this webinar is:Introduction: Legislative Basis and Criteria …

News
Press release

NHS spending on drugs fell in 2011

April 4, 2012
Sales and Marketing NHS, cost savings, generic, patent, prescriptions, spend

The NHS in England spent less on its drugs budget last year, bucking the longstanding upward trend. This is because …

News
GSK image

GSK’s diabetes drug misses goal

April 4, 2012
Research and Development, Sales and Marketing Bydureon, GSK, Victoza, albiglutide, diabetes

GlaxoSmithKline has insisted its new long-acting Type 2 diabetes drug albiglutide remains on course for filing following topline results from …

News

EMG appoints two new senior members

April 4, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing EMG, Matthew Speers, Steve Turley, UCB

A new chair and vice-chair have been appointed to lead the European Medicines Group (EMG).   EMG is the voice of …

Appointment

Glyn Edwards appointed as chief executive of Summit

April 4, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Glyn Edwards, summit

Summit, a UK drug discovery company, has appointed Glyn Edwards as its new chief executive. Edwards will take up the …

Appointment

EMA creates new conflict of interest rules

April 4, 2012
Sales and Marketing EMA, Lonngren, conflict of interest

The European Medicines Agency has introduced new rules to tighten up conflicts of interest, and have less reliance on pharma …

News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026